Home > News > Tiny bubbles?
July 30th, 2004
If Nanosys, which is scheduled to go public next week, prices at the high end of its $15 to $17 a share range, it would debut with a market value of about $372 million. So it would be trading at nearly 125 times last year's sales! Is a company that warns in its prospectus that it has yet to develop any products and may not do so for several years, if ever, really worth buying now?
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014